V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006944 | 330013289 | 1.77 | 62.6 | Neo-adjuvant (N) | null | 2015-07-08 | Cisplatin 7 day | N | N | 330005964 | CISPLATIN |
| 330006945 | 330013289 | 1.55 | 48.6 | Neo-adjuvant (N) | 2012-02-24 | 2013-11-05 | DOXORUBICIN | 1 | N | 330005964 | DOXORUBICIN |
| 330006946 | 330003721 | 1.79 | 48.6 | Neo-adjuvant (N) | 2017-04-15 | 2017-04-15 | Mifamurtide weeks 1-12 | 2 | N | 330005985 | MIFAMURTIDE |
| 330006947 | 330003721 | 1.52 | 77.1 | Adjuvant (A) | 2013-07-22 | 2014-01-08 | Doxorubicin 75mg/m2 | Y | N | 330005985 | DOXORUBICIN |
| 330006948 | 330003721 | 1.6 | 72.1 | Curative (C) | null | 2014-09-16 | MIFAMURTIDE | 02 | N | 330005985 | MIFAMURTIDE |
| 330006951 | 330003726 | 1.67 | 97.3 | Adjuvant (A) | 2012-03-26 | 2015-01-16 | MIFAMURTIDE | 02 | N | 330006006 | MIFAMURTIDE |
| 330006952 | 330003728 | 1.73 | 77.9 | Adjuvant (A) | 2017-01-22 | 2017-01-22 | Cisplatin | Y | N | 330006006 | CISPLATIN |
| 330006953 | 330003729 | 1.78 | 75 | Neo-adjuvant (N) | 2014-07-09 | 2014-08-17 | METHOTREXATE | N | N | 330006015 | METHOTREXATE |
| 330006954 | 330008010 | 1.7 | 113 | Curative (C) | null | 2015-08-07 | Cisplatin 7 day | N | Y | 330006016 | CISPLATIN |
| 330006955 | 330003733 | 1.71 | 60.55 | Curative (C) | 2015-12-01 | 2015-12-15 | OST Euramos 1 Closed Trial - A | N | Y | 330006017 | DOXORUBICIN |
| 330006956 | 330003734 | 0 | 82.4 | Neo-adjuvant (N) | 2017-09-23 | 2017-09-23 | EW EuroEwing 2012 Arm B IE | Y | null | 330006023 | TRIAL |
| 330006957 | 330003735 | 1.77 | 68.5 | Curative (C) | null | 2013-12-09 | Cisplatin | null | null | 330006031 | CISPLATIN |
| 330006958 | 330003735 | 1.77 | 92.3 | Disease modification (D) | 2017-08-01 | 2017-08-15 | Trial Unspecified | 02 | N | 330006031 | TRIAL |
| 330006959 | 330003735 | 0 | 17.4 | Palliative (P) | 2013-09-29 | 2015-10-26 | Doxorubicin 75mg/m2 | 02 | N | 330006031 | DOXORUBICIN |
| 330006960 | 330003736 | 1.67 | 28.6 | Neo-adjuvant (N) | 2014-05-18 | 2014-06-29 | Cisplatin | Y | N | 330006041 | CISPLATIN |
| 330006961 | 330003736 | 1.69 | 104.3 | null | 2013-08-29 | 2013-11-04 | Cisplatin | N | N | 330006041 | CISPLATIN |
| 330006963 | 330003738 | 0 | 53.2 | Curative (C) | 2016-06-10 | 2016-08-02 | Cisplatin 7 day | 2 | N | 330006053 | CISPLATIN |
| 330006964 | 330003738 | 1.75 | 75.1 | Neo-adjuvant (N) | null | 2013-07-12 | METHOTREXATE | N | null | 330006053 | METHOTREXATE |
| 330006965 | 330003742 | 0 | 54 | Neo-adjuvant (N) | 2013-12-31 | 2014-02-28 | EW EuroEwing 2012 Arm B IE | N | N | 330006058 | TRIAL |
| 330006966 | 330003743 | 1.76 | 89.4 | Neo-adjuvant (N) | 2017-11-26 | 2017-11-26 | EW EuroEwing 2012 Arm A VAI | N | N | 330006113 | TRIAL |
| 330006969 | 330003746 | null | 32.5 | Curative (C) | 2014-01-09 | 2014-01-16 | ESPHALL TRIAL | 1 | N | 330006497 | TRIAL |
| 330006970 | 330003748 | 1.89 | 39.1 | Curative (C) | 2013-08-31 | 2013-12-10 | Trial Unspecified | 02 | N | 330006633 | TRIAL |
| 330006971 | 330003748 | 1.65 | 52.65 | Neo-adjuvant (N) | null | 2013-08-09 | METHOTREXATE | 02 | Y | 330006633 | METHOTREXATE |
| 330006972 | 330003748 | 1.8 | 84.4 | Adjuvant (A) | 2016-08-14 | 2017-06-03 | DOXORUBICIN | N | Y | 330006633 | DOXORUBICIN |
| 330006973 | 330003749 | 1.73 | 88.2 | Curative (C) | 2014-05-06 | 2014-05-12 | Trial Unspecified | null | null | 330006926 | TRIAL |
| 330006974 | 330012763 | 1.7 | 87.6 | Neo-adjuvant (N) | 2016-07-28 | 2016-11-08 | DOXORUBICIN | N | N | 330007179 | DOXORUBICIN |
| 330006975 | 330012763 | 1.1 | 65.8 | Curative (C) | null | 2017-09-17 | METHOTREXATE | null | null | 330007179 | METHOTREXATE |
| 330006976 | 330003752 | null | 40.6 | Adjuvant (A) | 2016-10-21 | 2017-04-29 | DOXORUBICIN | null | N | 330007189 | DOXORUBICIN |
| 330006977 | 330003753 | null | 74.1 | Curative (C) | 2013-01-04 | 2013-04-18 | Mifamurtide weeks 1-12 | null | N | 330007189 | MIFAMURTIDE |
| 330006978 | 330010353 | null | 60.4 | Curative (C) | 2016-09-03 | 2016-11-10 | Cisplatin 7 day | N | N | 330007202 | CISPLATIN |
| 330006979 | 330010353 | 1.82 | null | Curative (C) | null | 2014-02-03 | Cisplatin 7 day | 02 | N | 330007202 | CISPLATIN |
| 330006980 | 330010353 | null | 88 | Curative (C) | null | 2016-03-27 | DOXORUBICIN | N | Y | 330007202 | DOXORUBICIN |
| 330006981 | 330010353 | 1.62 | 52.65 | Curative (C) | 2016-07-21 | 2016-07-21 | Trial Unspecified | N | N | 330007202 | TRIAL |
| 330006982 | 330003756 | 1.62 | 63.8 | Neo-adjuvant (N) | 2017-08-25 | 2017-11-15 | METHOTREXATE | N | null | 330007212 | METHOTREXATE |
| 330006984 | 330008030 | 1.79 | 45.7 | Curative (C) | 2013-12-21 | 2014-01-06 | Cisplatin 7 day | Y | N | 330007214 | CISPLATIN |
| 330006985 | 330003762 | null | 52.9 | null | 2012-12-18 | 2013-04-22 | OST Mifamurtide | N | N | 330007229 | MIFAMURTIDE |
| 330006986 | 330003763 | 0 | 39.3 | Curative (C) | 2018-01-04 | 2018-03-15 | EW EuroEwing 2012 Arm B IE | Y | N | 330007231 | TRIAL |
| 330006987 | 330003763 | 1.77 | 45.5 | Curative (C) | 2016-08-17 | 2016-09-21 | Trial Unspecified | 01 | N | 330007231 | TRIAL |
| 330006988 | 330003763 | 1.6 | 54 | Neo-adjuvant (N) | null | 2014-04-04 | Cisplatin | null | null | 330007231 | CISPLATIN |
| 330006989 | 330003766 | 0 | 61.2 | Neo-adjuvant (N) | 2014-10-06 | 2014-10-06 | MIFAMURTIDE | 02 | N | 330007248 | MIFAMURTIDE |
| 330006990 | 330003770 | 1.68 | 72 | Curative (C) | 2014-12-25 | 2015-09-03 | MIFAMURTIDE | N | N | 330007251 | MIFAMURTIDE |
| 330006991 | 330008035 | 1.79 | 82.7 | Neo-adjuvant (N) | 2015-03-07 | 2015-05-29 | EW EuroEwing 2012 Arm B VDC | N | null | 330007251 | TRIAL |
| 330006992 | 330008035 | 1.8 | null | Neo-adjuvant (N) | 2015-02-19 | 2015-02-19 | DOXORUBICIN | N | N | 330007251 | DOXORUBICIN |
| 330006993 | 330008035 | 1.81 | 102 | Palliative (P) | 2014-09-12 | 2015-02-07 | CNS Medbl HR Cyclo+Vinc | N | N | 330007251 | TRIAL |
| 330006994 | 330003772 | 1.72 | 63.05 | Adjuvant (A) | 2017-03-18 | 2017-03-19 | OST Euramos 1 Closed Trial - A | N | N | 330007260 | DOXORUBICIN |
| 330006996 | 330010360 | null | 45.5 | null | null | 2015-06-25 | MIFAMURTIDE | null | null | 330007290 | MIFAMURTIDE |
| 330006997 | 330003776 | 1.8 | 28.6 | Neo-adjuvant (N) | 2016-05-11 | 2016-05-11 | METHOTREXATE | 02 | N | 330007290 | METHOTREXATE |
| 330006998 | 330008039 | 1.72 | 92.5 | Neo-adjuvant (N) | 2015-06-27 | 2015-09-02 | Cisplatin 7 day | N | Y | 330007308 | CISPLATIN |
| 330006999 | 330008039 | null | 73.5 | Curative (C) | null | 2015-04-04 | OST Mifamurtide | null | null | 330007308 | MIFAMURTIDE |
| 330007000 | 330003780 | 1.7 | 71 | Neo-adjuvant (N) | null | 2018-12-05 | METHOTREXATE | null | null | 330007315 | METHOTREXATE |